Summary

The computational biology market is witnessing rapid advancement as the integration of biological sciences with computational technologies continues to reshape modern research. This interdisciplinary field is becoming increasingly essential for decoding complex biological systems, enabling researchers to analyze massive datasets and generate actionable insights. From drug discovery to genomics and clinical trial optimization, computational biology is playing a vital role in accelerating scientific innovation and improving healthcare outcomes across the globe.

Market Insights

The global computational biology market is estimated to reach 7.9 billion in 2026 and is projected to expand to 17.5 billion by 2033, reflecting a robust compound annual growth rate of 12.00% during the forecast period. This significant growth is driven by the increasing reliance on data-intensive research methodologies and the widespread adoption of advanced computational tools in life sciences. The surge in genomic and proteomic data generation, combined with the growing need for accurate predictive models, is fueling demand for sophisticated computational platforms. Additionally, advancements in artificial intelligence and machine learning are enhancing the capabilities of computational biology solutions, further strengthening market expansion.

Drivers

A key driver of the computational biology market is the rapid growth of high-throughput technologies, which generate vast volumes of biological data requiring advanced analysis tools. Researchers and organizations are increasingly adopting computational biology to manage, interpret, and derive meaningful insights from these datasets. The rising emphasis on precision medicine is also contributing to market growth, as computational tools enable the identification of disease-specific biomarkers and tailored treatment strategies.

Another major factor driving the market is the increasing investment in pharmaceutical and biotechnology research. Computational biology helps reduce the cost and time associated with drug discovery by enabling in silico testing, predictive modeling, and simulation of biological processes. These capabilities are particularly valuable in addressing complex diseases and improving the efficiency of preclinical and clinical development processes. Furthermore, the growing prevalence of chronic diseases worldwide is encouraging the adoption of advanced research techniques, thereby supporting market growth.

Business Opportunity

The computational biology market offers considerable opportunities for technology providers and service companies. The adoption of cloud-based platforms is transforming the way biological data is stored, accessed, and analyzed. Cloud integration allows researchers to collaborate seamlessly and access scalable computational resources, making it a key growth area for market participants.

In addition, the incorporation of artificial intelligence and machine learning into computational biology solutions is creating new avenues for innovation. Companies that develop advanced analytics tools, simulation software, and integrated data platforms are likely to benefit from the increasing demand for efficient research solutions. Emerging economies are also presenting significant growth opportunities, as governments and private organizations invest in biotechnology infrastructure and research capabilities.

The growing focus on personalized medicine and biomarker discovery further enhances the market’s potential. Organizations that specialize in genomics, proteomics, and computational drug modeling are expected to gain a competitive advantage as demand for targeted therapies continues to rise.

Region Analysis

North America holds a dominant position in the computational biology market, supported by a strong presence of leading pharmaceutical and biotechnology companies, advanced research facilities, and substantial funding from government agencies. The region is also a pioneer in adopting innovative technologies such as artificial intelligence and big data analytics in life sciences research.

Europe represents a significant market, driven by increasing research collaborations and a strong emphasis on healthcare innovation. The region is benefiting from advancements in genomics and personalized medicine, which are contributing to the growing adoption of computational biology tools.

Asia Pacific is anticipated to register the fastest growth during the forecast period. The region is witnessing increased investment in healthcare and biotechnology, along with the expansion of research institutions and academic centers. The adoption of computational biology solutions is rising as countries aim to enhance their research capabilities and improve healthcare delivery.

Latin America and the Middle East & Africa are emerging markets with promising growth potential. Although their current market share is relatively smaller, improving infrastructure, rising awareness, and increasing investment in healthcare are expected to drive future expansion.

Key Players

The computational biology market is highly competitive, with several prominent players focusing on technological advancements and strategic collaborations to strengthen their market presence. Key companies operating in the market include:

• Thermo Fisher Scientific Inc.

• Illumina, Inc.

• QIAGEN N.V.

• Bio-Rad Laboratories, Inc.

• Dassault Systèmes SE

• DNAnexus, Inc.

• Schrödinger, Inc.

• Compugen Ltd.

• Genedata AG

• Simulations Plus, Inc.

• Fios Genomics

• Aganitha AI Inc.

• Certara, Inc.

• Chemical Computing Group ULC

• Insilico Biotechnology AG

These companies are investing heavily in research and development, expanding their product offerings, and forming partnerships to stay competitive. The integration of artificial intelligence and advanced analytics into computational biology platforms is a key focus area for these players.

Segmentation

By Service

• Databases

• Infrastructure & Hardware

• Software Platform

By Application

• Drug Discovery & Disease Modelling

o Target Identification

o Target Validation

o Lead Discovery

o Lead optimization

• Preclinical Drug Development

o Pharmacokinetics

o Pharmacodynamics

• Clinical Trial

o Phase I

o Phase II

o Phase III

o Phase IV

• Computational Genomics

• Computational Proteomics

• Others

By End-use

• Academic & Research

• Industrial

By Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Computational Biology Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Five Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
2.9.1. Current Prices and Future Projections, 2025-2033
2.9.2. Price Impact Factors
3. Global Computational Biology Market Outlook, 2020 - 2033
3.1. Global Computational Biology Market Outlook, by Service, Value (US$ Bn), 2020-2033
3.1.1. Databases
3.1.2. Infrastructure & Hardware
3.1.3. Software Platform
3.2. Global Computational Biology Market Outlook, by Application, Value (US$ Bn), 2020-2033
3.2.1. Drug Discovery & Disease Modelling
3.2.1.1. Target Identification
3.2.1.2. Target Validation
3.2.1.3. Lead Discovery
3.2.1.4. Lead optimization
3.2.2. Preclinical Drug Development
3.2.2.1. Pharmacokinetics
3.2.2.2. Pharmacodynamics
3.2.3. Clinical Trial
3.2.3.1. Phase I
3.2.3.2. Phase II
3.2.3.3. Phase III
3.2.3.4. Phase IV
3.2.4. Computational Genomics
3.2.5. Computational Proteomics
3.2.6. Others
3.3. Global Computational Biology Market Outlook, by End-use, Value (US$ Bn), 2020-2033
3.3.1. Academic & Research
3.3.2. Industrial
3.4. Global Computational Biology Market Outlook, by Region, Value (US$ Bn), 2020-2033
3.4.1. North America
3.4.2. Europe
3.4.3. Asia Pacific
3.4.4. Latin America
3.4.5. Middle East & Africa
4. North America Computational Biology Market Outlook, 2020 - 2033
4.1. North America Computational Biology Market Outlook, by Service, Value (US$ Bn), 2020-2033
4.1.1. Databases
4.1.2. Infrastructure & Hardware
4.1.3. Software Platform
4.2. North America Computational Biology Market Outlook, by Application, Value (US$ Bn), 2020-2033
4.2.1. Drug Discovery & Disease Modelling
4.2.1.1. Target Identification
4.2.1.2. Target Validation
4.2.1.3. Lead Discovery
4.2.1.4. Lead optimization
4.2.2. Preclinical Drug Development
4.2.2.1. Pharmacokinetics
4.2.2.2. Pharmacodynamics
4.2.3. Clinical Trial
4.2.3.1. Phase I
4.2.3.2. Phase II
4.2.3.3. Phase III
4.2.3.4. Phase IV
4.2.4. Computational Genomics
4.2.5. Computational Proteomics
4.2.6. Others
4.3. North America Computational Biology Market Outlook, by End-use, Value (US$ Bn), 2020-2033
4.3.1. Academic & Research
4.3.2. Industrial
4.4. North America Computational Biology Market Outlook, by Country, Value (US$ Bn), 2020-2033
4.4.1. U.S. Computational Biology Market Outlook, by Service, 2020-2033
4.4.2. U.S. Computational Biology Market Outlook, by Application, 2020-2033
4.4.3. U.S. Computational Biology Market Outlook, by End-use, 2020-2033
4.4.4. Canada Computational Biology Market Outlook, by Service, 2020-2033
4.4.5. Canada Computational Biology Market Outlook, by Application, 2020-2033
4.4.6. Canada Computational Biology Market Outlook, by End-use, 2020-2033
4.5. BPS Analysis/Market Attractiveness Analysis
5. Europe Computational Biology Market Outlook, 2020 - 2033
5.1. Europe Computational Biology Market Outlook, by Service, Value (US$ Bn), 2020-2033
5.1.1. Databases
5.1.2. Infrastructure & Hardware
5.1.3. Software Platform
5.2. Europe Computational Biology Market Outlook, by Application, Value (US$ Bn), 2020-2033
5.2.1. Drug Discovery & Disease Modelling
5.2.1.1. Target Identification
5.2.1.2. Target Validation
5.2.1.3. Lead Discovery
5.2.1.4. Lead optimization
5.2.2. Preclinical Drug Development
5.2.2.1. Pharmacokinetics
5.2.2.2. Pharmacodynamics
5.2.3. Clinical Trial
5.2.3.1. Phase I
5.2.3.2. Phase II
5.2.3.3. Phase III
5.2.3.4. Phase IV
5.2.4. Computational Genomics
5.2.5. Computational Proteomics
5.2.6. Others
5.3. Europe Computational Biology Market Outlook, by End-use, Value (US$ Bn), 2020-2033
5.3.1. Academic & Research
5.3.2. Industrial
5.4. Europe Computational Biology Market Outlook, by Country, Value (US$ Bn), 2020-2033
5.4.1. Germany Computational Biology Market Outlook, by Service, 2020-2033
5.4.2. Germany Computational Biology Market Outlook, by Application, 2020-2033
5.4.3. Germany Computational Biology Market Outlook, by End-use, 2020-2033
5.4.4. Italy Computational Biology Market Outlook, by Service, 2020-2033
5.4.5. Italy Computational Biology Market Outlook, by Application, 2020-2033
5.4.6. Italy Computational Biology Market Outlook, by End-use, 2020-2033
5.4.7. France Computational Biology Market Outlook, by Service, 2020-2033
5.4.8. France Computational Biology Market Outlook, by Application, 2020-2033
5.4.9. France Computational Biology Market Outlook, by End-use, 2020-2033
5.4.10. U.K. Computational Biology Market Outlook, by Service, 2020-2033
5.4.11. U.K. Computational Biology Market Outlook, by Application, 2020-2033
5.4.12. U.K. Computational Biology Market Outlook, by End-use, 2020-2033
5.4.13. Spain Computational Biology Market Outlook, by Service, 2020-2033
5.4.14. Spain Computational Biology Market Outlook, by Application, 2020-2033
5.4.15. Spain Computational Biology Market Outlook, by End-use, 2020-2033
5.4.16. Russia Computational Biology Market Outlook, by Service, 2020-2033
5.4.17. Russia Computational Biology Market Outlook, by Application, 2020-2033
5.4.18. Russia Computational Biology Market Outlook, by End-use, 2020-2033
5.4.19. Rest of Europe Computational Biology Market Outlook, by Service, 2020-2033
5.4.20. Rest of Europe Computational Biology Market Outlook, by Application, 2020-2033
5.4.21. Rest of Europe Computational Biology Market Outlook, by End-use, 2020-2033
5.5. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Computational Biology Market Outlook, 2020 - 2033
6.1. Asia Pacific Computational Biology Market Outlook, by Service, Value (US$ Bn), 2020-2033
6.1.1. Databases
6.1.2. Infrastructure & Hardware
6.1.3. Software Platform
6.2. Asia Pacific Computational Biology Market Outlook, by Application, Value (US$ Bn), 2020-2033
6.2.1. Drug Discovery & Disease Modelling
6.2.1.1. Target Identification
6.2.1.2. Target Validation
6.2.1.3. Lead Discovery
6.2.1.4. Lead optimization
6.2.2. Preclinical Drug Development
6.2.2.1. Pharmacokinetics
6.2.2.2. Pharmacodynamics
6.2.3. Clinical Trial
6.2.3.1. Phase I
6.2.3.2. Phase II
6.2.3.3. Phase III
6.2.3.4. Phase IV
6.2.4. Computational Genomics
6.2.5. Computational Proteomics
6.2.6. Others
6.3. Asia Pacific Computational Biology Market Outlook, by End-use, Value (US$ Bn), 2020-2033
6.3.1. Academic & Research
6.3.2. Industrial
6.4. Asia Pacific Computational Biology Market Outlook, by Country, Value (US$ Bn), 2020-2033
6.4.1. China Computational Biology Market Outlook, by Service, 2020-2033
6.4.2. China Computational Biology Market Outlook, by Application, 2020-2033
6.4.3. China Computational Biology Market Outlook, by End-use, 2020-2033
6.4.4. Japan Computational Biology Market Outlook, by Service, 2020-2033
6.4.5. Japan Computational Biology Market Outlook, by Application, 2020-2033
6.4.6. Japan Computational Biology Market Outlook, by End-use, 2020-2033
6.4.7. South Korea Computational Biology Market Outlook, by Service, 2020-2033
6.4.8. South Korea Computational Biology Market Outlook, by Application, 2020-2033
6.4.9. South Korea Computational Biology Market Outlook, by End-use, 2020-2033
6.4.10. India Computational Biology Market Outlook, by Service, 2020-2033
6.4.11. India Computational Biology Market Outlook, by Application, 2020-2033
6.4.12. India Computational Biology Market Outlook, by End-use, 2020-2033
6.4.13. Southeast Asia Computational Biology Market Outlook, by Service, 2020-2033
6.4.14. Southeast Asia Computational Biology Market Outlook, by Application, 2020-2033
6.4.15. Southeast Asia Computational Biology Market Outlook, by End-use, 2020-2033
6.4.16. Rest of SAO Computational Biology Market Outlook, by Service, 2020-2033
6.4.17. Rest of SAO Computational Biology Market Outlook, by Application, 2020-2033
6.4.18. Rest of SAO Computational Biology Market Outlook, by End-use, 2020-2033
6.5. BPS Analysis/Market Attractiveness Analysis
7. Latin America Computational Biology Market Outlook, 2020 - 2033
7.1. Latin America Computational Biology Market Outlook, by Service, Value (US$ Bn), 2020-2033
7.1.1. Databases
7.1.2. Infrastructure & Hardware
7.1.3. Software Platform
7.2. Latin America Computational Biology Market Outlook, by Application, Value (US$ Bn), 2020-2033
7.2.1. Drug Discovery & Disease Modelling
7.2.1.1. Target Identification
7.2.1.2. Target Validation
7.2.1.3. Lead Discovery
7.2.1.4. Lead optimization
7.2.2. Preclinical Drug Development
7.2.2.1. Pharmacokinetics
7.2.2.2. Pharmacodynamics
7.2.3. Clinical Trial
7.2.3.1. Phase I
7.2.3.2. Phase II
7.2.3.3. Phase III
7.2.3.4. Phase IV
7.2.4. Computational Genomics
7.2.5. Computational Proteomics
7.2.6. Others
7.3. Latin America Computational Biology Market Outlook, by End-use, Value (US$ Bn), 2020-2033
7.3.1. Academic & Research
7.3.2. Industrial
7.4. Latin America Computational Biology Market Outlook, by Country, Value (US$ Bn), 2020-2033
7.4.1. Brazil Computational Biology Market Outlook, by Service, 2020-2033
7.4.2. Brazil Computational Biology Market Outlook, by Application, 2020-2033
7.4.3. Brazil Computational Biology Market Outlook, by End-use, 2020-2033
7.4.4. Mexico Computational Biology Market Outlook, by Service, 2020-2033
7.4.5. Mexico Computational Biology Market Outlook, by Application, 2020-2033
7.4.6. Mexico Computational Biology Market Outlook, by End-use, 2020-2033
7.4.7. Argentina Computational Biology Market Outlook, by Service, 2020-2033
7.4.8. Argentina Computational Biology Market Outlook, by Application, 2020-2033
7.4.9. Argentina Computational Biology Market Outlook, by End-use, 2020-2033
7.4.10. Rest of LATAM Computational Biology Market Outlook, by Service, 2020-2033
7.4.11. Rest of LATAM Computational Biology Market Outlook, by Application, 2020-2033
7.4.12. Rest of LATAM Computational Biology Market Outlook, by End-use, 2020-2033
7.5. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Computational Biology Market Outlook, 2020 - 2033
8.1. Middle East & Africa Computational Biology Market Outlook, by Service, Value (US$ Bn), 2020-2033
8.1.1. Databases
8.1.2. Infrastructure & Hardware
8.1.3. Software Platform
8.2. Middle East & Africa Computational Biology Market Outlook, by Application, Value (US$ Bn), 2020-2033
8.2.1. Drug Discovery & Disease Modelling
8.2.1.1. Target Identification
8.2.1.2. Target Validation
8.2.1.3. Lead Discovery
8.2.1.4. Lead optimization
8.2.2. Preclinical Drug Development
8.2.2.1. Pharmacokinetics
8.2.2.2. Pharmacodynamics
8.2.3. Clinical Trial
8.2.3.1. Phase I
8.2.3.2. Phase II
8.2.3.3. Phase III
8.2.3.4. Phase IV
8.2.4. Computational Genomics
8.2.5. Computational Proteomics
8.2.6. Others
8.3. Middle East & Africa Computational Biology Market Outlook, by End-use, Value (US$ Bn), 2020-2033
8.3.1. Academic & Research
8.3.2. Industrial
8.4. Middle East & Africa Computational Biology Market Outlook, by Country, Value (US$ Bn), 2020-2033
8.4.1. GCC Computational Biology Market Outlook, by Service, 2020-2033
8.4.2. GCC Computational Biology Market Outlook, by Application, 2020-2033
8.4.3. GCC Computational Biology Market Outlook, by End-use, 2020-2033
8.4.4. South Africa Computational Biology Market Outlook, by Service, 2020-2033
8.4.5. South Africa Computational Biology Market Outlook, by Application, 2020-2033
8.4.6. South Africa Computational Biology Market Outlook, by End-use, 2020-2033
8.4.7. Egypt Computational Biology Market Outlook, by Service, 2020-2033
8.4.8. Egypt Computational Biology Market Outlook, by Application, 2020-2033
8.4.9. Egypt Computational Biology Market Outlook, by End-use, 2020-2033
8.4.10. Nigeria Computational Biology Market Outlook, by Service, 2020-2033
8.4.11. Nigeria Computational Biology Market Outlook, by Application, 2020-2033
8.4.12. Nigeria Computational Biology Market Outlook, by End-use, 2020-2033
8.4.13. Rest of Middle East Computational Biology Market Outlook, by Service, 2020-2033
8.4.14. Rest of Middle East Computational Biology Market Outlook, by Application, 2020-2033
8.4.15. Rest of Middle East Computational Biology Market Outlook, by End-use, 2020-2033
8.5. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Thermo Fisher Scientific Inc.
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Developments
9.4.2. Illumina, Inc.
9.4.3. QIAGEN N.V.
9.4.4. Bio-Rad Laboratories, Inc.
9.4.5. Dassault Systèmes SE
9.4.6. DNAnexus, Inc.
9.4.7. Schrödinger, Inc.
9.4.8. Compugen Ltd.
9.4.9. Genedata AG
9.4.10. Simulations Plus, Inc.
9.4.11. Fios Genomics
9.4.12. Aganitha AI Inc.
9.4.13. Certara, Inc.
9.4.14. Chemical Computing Group ULC
9.4.15. Insilico Biotechnology AG
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations